156 related articles for article (PubMed ID: 7599047)
21. Immunohistochemical detection of bcl-2 protein in adenocarcinoma and non-neoplastic cellular compartments of the lung.
Rao SK; Krishna M; Woda BA; Savas L; Fraire AE
Mod Pathol; 1996 May; 9(5):555-9. PubMed ID: 8733771
[TBL] [Abstract][Full Text] [Related]
22. Combined expression of p53, Bcl-2, and p21WAF-1 proteins in lung cancer and premalignant lesions: association with clinical characteristics.
Kalomenidis I; Orphanidou D; Papamichalis G; Vassilakopoulos T; Scorilas A; Rasidakis A; Papastamatiou H; Jordanoglou J; Roussos C
Lung; 2001; 179(5):265-78. PubMed ID: 11976895
[TBL] [Abstract][Full Text] [Related]
23. A randomized phase IIb trial of pulmicort turbuhaler (budesonide) in people with dysplasia of the bronchial epithelium.
Lam S; leRiche JC; McWilliams A; Macaulay C; Dyachkova Y; Szabo E; Mayo J; Schellenberg R; Coldman A; Hawk E; Gazdar A
Clin Cancer Res; 2004 Oct; 10(19):6502-11. PubMed ID: 15475437
[TBL] [Abstract][Full Text] [Related]
24. Expression of Bcl-X(L), an antiapoptotic member of the Bcl-2 family, in esophageal squamous cell carcinoma.
Torzewski M; Sarbia M; Heep H; Dutkowski P; Willers R; Gabbert HE
Clin Cancer Res; 1998 Mar; 4(3):577-83. PubMed ID: 9533524
[TBL] [Abstract][Full Text] [Related]
25. Evidence of reciprocity of bcl-2 and p53 expression in human colorectal adenomas and carcinomas.
Watson AJ; Merritt AJ; Jones LS; Askew JN; Anderson E; Becciolini A; Balzi M; Potten CS; Hickman JA
Br J Cancer; 1996 Apr; 73(8):889-95. PubMed ID: 8611422
[TBL] [Abstract][Full Text] [Related]
26. bcl-2 expression in the spectrum of preinvasive breast lesions.
Siziopikou KP; Prioleau JE; Harris JR; Schnitt SJ
Cancer; 1996 Feb; 77(3):499-506. PubMed ID: 8630957
[TBL] [Abstract][Full Text] [Related]
27. Immunohistochemical expression of Bcl-2 protein in breast lesions: correlation with Bax, p53, Rb, C-erbB-2, EGFR and proliferation indices.
Ioachim EE; Malamou-Mitsi V; Kamina SA; Goussia AC; Agnantis NJ
Anticancer Res; 2000; 20(6B):4221-5. PubMed ID: 11205251
[TBL] [Abstract][Full Text] [Related]
28. Bcl-2 protein expression in carcinomas originating from the follicular epithelium of the thyroid gland.
Pilotti S; Collini P; Rilke F; Cattoretti G; Del Bo R; Pierotti MA
J Pathol; 1994 Apr; 172(4):337-42. PubMed ID: 8207614
[TBL] [Abstract][Full Text] [Related]
29. bcl-2 and p53 protein expression in non-small cell lung cancers: correlation with survival time.
Ohsaki Y; Toyoshima E; Fujiuchi S; Matsui H; Hirata S; Miyokawa N; Kubo Y; Kikuchi K
Clin Cancer Res; 1996 May; 2(5):915-20. PubMed ID: 9816250
[TBL] [Abstract][Full Text] [Related]
30. Biological features of bronchial squamous dysplasia followed up by autofluorescence bronchoscopy.
Hoshino H; Shibuya K; Chiyo M; Iyoda A; Yoshida S; Sekine Y; Iizasa T; Saitoh Y; Baba M; Hiroshima K; Ohwada H; Fujisawa T
Lung Cancer; 2004 Nov; 46(2):187-96. PubMed ID: 15474667
[TBL] [Abstract][Full Text] [Related]
31. Combined and sequential expression of p53, Rb, Ras and Bcl-2 in bronchial preneoplastic lesions.
Ferron PE; Bagni I; Guidoboni M; Beccati MD; Nenci I
Tumori; 1997; 83(2):587-93. PubMed ID: 9226026
[TBL] [Abstract][Full Text] [Related]
32. Detection of p53 and bcl-2 protein in carcinoma of the renal pelvis and ureter including dysplasia.
Furihata M; Sonobe H; Ohtsuki Y; Yamashita M; Morioka M; Yamamoto A; Terao N; Kuwahara M; Fujisaki N
J Pathol; 1996 Feb; 178(2):133-9. PubMed ID: 8683378
[TBL] [Abstract][Full Text] [Related]
33. Apoptotic markers p53, Bcl-2 and Bax in primary lung cancer.
Porebska I; Wyrodek E; Kosacka M; Adamiak J; Jankowska R; Harłozińska-Szmyrka A
In Vivo; 2006; 20(5):599-604. PubMed ID: 17091766
[TBL] [Abstract][Full Text] [Related]
34. p53 mutations and p53, Waf-1, Bax and Bcl-2 expression in field cancerization of the head and neck.
Lavieille JP; Gazzeri S; Riva C; Reyt E; Brambilla C; Brambilla E
Anticancer Res; 1998; 18(6B):4741-9. PubMed ID: 9891551
[TBL] [Abstract][Full Text] [Related]
35. Changes in the expression of matrix proteases and of the transcription factor c-Ets-1 during progression of precancerous bronchial lesions.
Bolon I; Brambilla E; Vandenbunder B; Robert C; Lantuejoul S; Brambilla C
Lab Invest; 1996 Jul; 75(1):1-13. PubMed ID: 8683934
[TBL] [Abstract][Full Text] [Related]
36. Altered patterns of retinoblastoma gene product expression in benign, premalignant and malignant epithelium of the larynx: an immunohistochemical study including correlation with p53, bcl-2 and proliferating indices.
Ioachim E; Assimakopoulos D; Agnantis NJ; Peschos D; Zissi A; Skevas A
Anticancer Res; 1999; 19(1A):541-5. PubMed ID: 10226595
[TBL] [Abstract][Full Text] [Related]
37. Analysis of p53, K-ras-2, and C-raf-1 in pulmonary neuroendocrine tumors. Correlation with histological subtype and clinical outcome.
Przygodzki RM; Finkelstein SD; Langer JC; Swalsky PA; Fishback N; Bakker A; Guinee DG; Koss M; Travis WD
Am J Pathol; 1996 May; 148(5):1531-41. PubMed ID: 8623922
[TBL] [Abstract][Full Text] [Related]
38. [Expression of p53, p21 and bcl-2 in prognosis of lung carcinomas].
Nhung NV; Mirejovský T; Mirejovský P; Melínová L
Cesk Patol; 1999 Oct; 35(4):117-21. PubMed ID: 10677910
[TBL] [Abstract][Full Text] [Related]
39. bcl-2, p53 and proliferating cell nuclear antigen expression is related to the degree of differentiation in thyroid carcinomas.
Pollina L; Pacini F; Fontanini G; Vignati S; Bevilacqua G; Basolo F
Br J Cancer; 1996 Jan; 73(2):139-43. PubMed ID: 8546897
[TBL] [Abstract][Full Text] [Related]
40. Immunohistochemical expression of Bcl-2 and Ki-67 in oral lichen planus and leukoplakia with different degrees of dysplasia.
Pigatti FM; Taveira LA; Soares CT
Int J Dermatol; 2015 Feb; 54(2):150-5. PubMed ID: 25265990
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
